291 – 300 of 346
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section
(
- Contribution to journal › Article
-
Mark
Interstitial photodynamic therapy for primary prostate cancer incorporating realtime treatment dosimetry
2007) Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI 6427. p.4270-4270(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically-based screening strategy
(
- Contribution to journal › Article
-
Mark
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
What should a urologist know about hereditary predisposition to prostate cancer?
(
- Contribution to journal › Scientific review
-
Mark
Role of fibroblast growth factor 8 in growth and progression of hormonal cancer
(
- Contribution to journal › Scientific review
- 2006
-
Mark
The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus
(
- Contribution to journal › Article
-
Mark
Solution structures of human and porcine beta-microseminoprotein
(
- Contribution to journal › Article
-
Mark
CYSTATIN C AND NEUROENDOCRINE DIFFERENTIATION IN THE MALE REPRODUCTIVE SYSTEM AND IN PROSTATE CANCER
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Hormone therapy: Improving therapy decisions and monitoring
(
- Contribution to journal › Article